Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Drug crawled date : 2021 - 11 - 15 save search
Merck’s Anti-Cholesterol Drug Threatens Esperion, Other PCSK9 Inhibitor Makers
Published: 2021-11-15 (Crawled : 17:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.69%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.02%
H: 0.0%
C: 0.0%
drug cholesterol
Entos and BioMarin Enter into Agreement for Product Candidates Incorporating Entos' Fusogenix Drug Delivery Platform
Published: 2021-11-15 (Crawled : 14:30) - biospace.com/
BMRN S | $88.68 -1.54% -1.57% 1.8M
|
Health Technology
|
| O: 0.89%
H: 0.63%
C: -0.47%
drug drug delivery liver platform
Cell MedX Corp. Files Premarket Notification (510K) with the US Food and Drug Administration and Receives Canadian Trademark Copy
Published: 2021-11-15 (Crawled : 14:00) - cellmedx.com
CMXC | $0.048 -63.33% 1.5K
|
Manufacturing
|
| O: 1.6%
H: 53.34%
C: 28.64%
food ema drug
Junshi Biosciences and Coherus Announce Toripalimab Granted Orphan Drug Designation in the United States for Esophageal Cancer
Published: 2021-11-15 (Crawled : 13:30) - globenewswire.com
ABBV | News | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: -0.34%
H: 0.73%
C: -0.09%
CHRS | $2.06 3.0% 2.91% 2.9M
|
Health Technology
|
| O: 1.46%
H: 1.81%
C: 0.75%
orphan drug cancer drug granted designation
Coherus and Junshi Biosciences Announce Toripalimab Granted Orphan Drug Designation in the United States for Esophageal Cancer
Published: 2021-11-15 (Crawled : 13:30) - globenewswire.com
ABBV | News | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: -0.34%
H: 0.73%
C: -0.09%
CHRS | $2.06 3.0% 2.91% 2.9M
|
Health Technology
|
| O: 1.46%
H: 1.81%
C: 0.75%
orphan drug cancer drug granted designation
Rhythm Pharmaceuticals Announces FDA Acceptance for Filing and Priority Review of Supplemental New Drug Application for IMCIVREE® (setmelanotide)
Published: 2021-11-15 (Crawled : 13:00) - biospace.com/
RYTM A | $37.975 -0.35% -0.36% 620K
|
Health Technology
|
| O: -0.15%
H: 2.1%
C: -0.68%
new drug fda fda acceptance application setmelanotide drug imcivree
Trevi Therapeutics to Present at 5th Annual Dermatology Drug Development Summit for Inflammatory Skin Diseases
Published: 2021-11-15 (Crawled : 12:30) - prnewswire.com
TRVI | $2.82 5.03% 4.79% 140K
|
Health Technology
|
| O: -1.68%
H: 0.85%
C: -5.98%
disease drug skin
NanoViricides Completes Oral Gummies and Lung Inhalation Formulations Development for its Non-Mutagenic, Safe, Broad-Spectrum COVID-19 Clinical Drug Candidate, NV-CoV-2
Published: 2021-11-15 (Crawled : 12:30) - biospace.com/
NNVC | $1.1 -6.38% 0.0% 22K
|
Health Technology
|
| O: 9.27%
H: 0.0%
C: 0.0%
covid drug
Viridian Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for VRDN-001, an IGF-1R Antibody for the Treatment of Thyroid Eye Disease (TED)
Published: 2021-11-15 (Crawled : 12:00) - globenewswire.com
VRDN | $14.59 -3.76% -3.91% 1.5M
|
Health Care and Social Assistan...
|
| O: 3.83%
H: 0.0%
C: -0.67%
new drug disease fda clearance treatment fda eye application eye disease antibody drug clearance
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | News | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.